The impact of Rho-kinase inhibitor, "Fasudil", intracoronary bolus administration to improve refractory coronary vasospasm.
Komiyama K, Tejima T, Tanabe Y, Nishimura T, Kitamura K, Watanabe T, Shimada H, Iwasawa J, Matsushita N, Ishikawa T, Hojo R, Hayashi T, Nakai M, Yoshimura H, Tatsumoto A, Fukamizu S, Sakurada H.
Komiyama K, et al. Among authors: hojo r.
Cardiovasc Interv Ther. 2011 Sep;26(3):281-5. doi: 10.1007/s12928-011-0071-2. Epub 2011 Jun 18.
Cardiovasc Interv Ther. 2011.
PMID: 24122598